Literature DB >> 18809297

A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

Eliana Mariño1, Shane T Grey.   

Abstract

Type I diabetes mellitus is an autoimmune disease mediated by a selective immune-mediated destruction of the insulin containing beta cells within the pancreatic islets of Langerhans. T cells reactive to beta cell-derived antigens are critical for the pathogenesis of type I diabetes, indeed treatments that target T cells are currently in clinical trials. CD8+ T cells may play a particularly crucial role in the onset of hyperglycaemia, as they can mediate beta cell destruction late in the pathogenesis of diabetes. However, the precise steps by which beta cell-reactive CD8+ T cells are activated are poorly understood. In this review we speculate on the possibility that B cells are essential for the activation and expansion of pathogenic CD8+ T cells that cause final beta cell destruction. We also discuss the involvement of different B cell subsets in the aetiology of diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18809297     DOI: 10.1016/j.jaut.2008.04.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  12 in total

1.  Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.

Authors:  Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

2.  B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Authors:  Yuki Moritoki; Zhe-Xiong Lian; Keith Lindor; Joseph Tuscano; Koichi Tsuneyama; Weici Zhang; Yoshiyuki Ueno; Robert Dunn; Marilyn Kehry; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 3.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

4.  Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.

Authors:  Dongmei Han; Carlos A Leyva; Della Matheson; Davide Mineo; Shari Messinger; Bonnie B Blomberg; Ana Hernandez; Luigi F Meneghini; Gloria Allende; Jay S Skyler; Rodolfo Alejandro; Alberto Pugliese; Norma S Kenyon
Journal:  Clin Immunol       Date:  2011-02-24       Impact factor: 3.969

Review 5.  CD40 and autoimmunity: the dark side of a great activator.

Authors:  Anna L Peters; Laura L Stunz; Gail A Bishop
Journal:  Semin Immunol       Date:  2009-10       Impact factor: 11.130

Review 6.  Food safety.

Authors:  Andrea Borchers; Suzanne S Teuber; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-10       Impact factor: 8.667

7.  Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.

Authors:  Kamal D Puri; Michael R Gold
Journal:  Front Immunol       Date:  2012-08-23       Impact factor: 7.561

8.  B-cell cross-presentation of autologous antigen precipitates diabetes.

Authors:  Eliana Mariño; Bernice Tan; Lauren Binge; Charles R Mackay; Shane T Grey
Journal:  Diabetes       Date:  2012-07-24       Impact factor: 9.461

9.  Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.

Authors:  Sebastien Bertin-Maghit; Dimeng Pang; Brendan O'Sullivan; Shannon Best; Emily Duggan; Sanjoy Paul; Helen Thomas; Thomas W H Kay; Leonard C Harrison; Raymond Steptoe; Ranjeny Thomas
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

10.  Tight junction proteins expression and modulation in immune cells and multiple sclerosis.

Authors:  Ilana Mandel; Tamar Paperna; Lea Glass-Marmor; Anat Volkowich; Samih Badarny; Ilya Schwartz; Pnina Vardi; Ilana Koren; Ariel Miller
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.